Naturally occurring mutations at the acetylcholine receptor binding site independently alter ACh binding and channel gating.
By defining functional defects in a congenital myasthenic syndrome (CMS), we show that two mutant residues, located in a binding site region of the acetylcholine receptor (AChR) epsilon subunit, exert opposite effects on ACh binding and suppress channel gating. Single channel kinetic analysis reveals that the first mutation, epsilon N182Y, increases ACh affinity for receptors in the resting closed state, which promotes sequential occupancy of the binding sites and discloses rate constants for ACh occupancy of the nonmutant alphadelta site. Studies of the analogous mutation in the delta subunit, deltaN187Y, disclose rate constants for ACh occupancy of the nonmutant alpha epsilon site. The second CMS mutation, epsilon D175N, reduces ACh affinity for receptors in the resting closed state; occupancy of the mutant site still promotes gating because a large difference in affinity is maintained between closed and open states. epsilon D175N impairs overall gating, however, through an effect independent of ACh occupancy. When mapped on a structural model of the AChR binding site, epsilon N182Y localizes to the interface with the alpha subunit, and epsilon D175 to the entrance of the ACh binding cavity. Both epsilon N182Y and epsilon D175 show state specificity in affecting closed relative to desensitized state affinities, suggesting that the protein chain harboring epsilon N182 and epsilon D175 rearranges in the course of receptor desensitization. The overall results show that key residues at the ACh binding site differentially stabilize the agonist bound to closed, open and desensitized states, and provide a set point for gating of the channel.
D000109:Acetylcholine / Q000493:pharmacokinetics*; D000595:Amino Acid Sequence; D018929:Cell Culture Techniques; D002675:Child, Preschool; D004252:DNA Mutational Analysis; D004594:Electrophysiology; D006801:Humans; D015640:Ion Channel Gating / Q000502:physiology*; D007700:Kinetics; D008297:Male; D008969:Molecular Sequence Data; D009045:Motor Endplate / Q000473:pathology / Q000502:physiology*; D018482:Muscle, Skeletal / Q000166:cytology; D020294:Myasthenic Syndromes, Congenital / Q000235:genetics* / Q000503:physiopathology; D016133:Polymerase Chain Reaction; D011978:Receptors, Nicotinic / Q000235:genetics* / Q000502:physiology
D011978:Receptors, Nicotinic; D000109:Acetylcholine